Related Experiment Video
Updated: May 20, 2026
04:33
Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Beck Depression Inventory-Fast Screen (BDI-FS): an efficient tool for depression screening in patients with end-stage
Andrea Neitzer1, Sumi Sun, Sheila Doss
1Satellite Healthcare, San Jose, California 95128, USA. neitzera@satellitehealth.com
Hemodialysis International. International Symposium on Home Hemodialysis
|July 4, 2012
Summary
The Beck Depression Inventory-Fast Screen (BDI-FS) effectively screens for depression in end-stage renal disease (ESRD) patients undergoing conventional hemodialysis (CHD). This validated tool shows strong correlation with the BDI-II, aiding early detection in dialysis care.
Area of Science:
- Nephrology
- Psychiatry
- Clinical Psychology
Background:
- Depression is a prevalent comorbidity in patients with end-stage renal disease (ESRD).
- Accurate depression screening is crucial for timely intervention in ESRD patients undergoing conventional hemodialysis (CHD).
- Existing screening tools require validation within the specific context of CHD patients.
Purpose of the Study:
- To validate the Beck Depression Inventory-Fast Screen (BDI-FS) against the Beck Depression Inventory-II (BDI-II) for depression screening in CHD patients.
- To determine an optimal cutoff score for the BDI-FS in identifying depression risk among ESRD patients.
- To assess the efficiency and applicability of the BDI-FS in routine dialysis settings.
Main Methods:
- A cohort of 162 conventional hemodialysis (CHD) patients completed both the BDI-FS and BDI-II questionnaires.
- Pearson Correlation Coefficient was used to assess the agreement between BDI-FS and BDI-II scores in 134 patients.
- Receiver operating characteristic (ROC) curve analysis was performed to identify the optimal BDI-FS cutoff score.
Main Results:
- A strong positive correlation was observed between BDI-FS and BDI-II scores (Pearson r = 0.85, p < 0.0001).
- An optimal BDI-FS cutoff score of ≥4 demonstrated high sensitivity (97.2%) and specificity (91.8%) for detecting depression when compared to a BDI-II cutoff of ≥16.
- The prevalence of depressive symptoms was 28.7% (BDI-II) and 30.1% (BDI-FS), indicating a significant burden.
Conclusions:
- The Beck Depression Inventory-Fast Screen (BDI-FS) is a reliable and effective tool for screening depression in conventional hemodialysis (CHD) patients.
- The validated BDI-FS cutoff score of ≥4 facilitates accurate identification of ESRD patients at risk for depression.
- The BDI-FS can be readily integrated into routine dialysis care to improve mental health management for ESRD patients.
Related Concept Videos
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...